PubRank

Robert Huddart

Author PubWeight™ 54.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 2005 5.54
2 Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. Lancet Oncol 2011 3.32
3 Testicular germ-cell cancer. Lancet 2006 2.64
4 Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol 2008 2.56
5 The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 2005 2.26
6 Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet 2006 2.23
7 European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2007 2.21
8 Early outcomes of active surveillance for localized prostate cancer. BJU Int 2005 1.84
9 The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol 2009 1.70
10 Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011). Trials 2011 1.57
11 Amplification and overexpression of E2F3 in human bladder cancer. Oncogene 2004 1.52
12 Diethylstilbestrol in castration-resistant prostate cancer. BJU Int 2012 1.49
13 Prostate cancer patients' support and psychological care needs: Survey from a non-surgical oncology clinic. Psychooncology 2003 1.47
14 Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours. BJU Int 2012 1.39
15 European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 2007 1.37
16 Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 2005 1.23
17 Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int 2013 1.07
18 Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Genes Chromosomes Cancer 2008 1.05
19 Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature. Genes Chromosomes Cancer 2008 1.01
20 Predictors of histological disease progression in untreated, localized prostate cancer. J Urol 2007 1.00
21 Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer. Int J Radiat Oncol Biol Phys 2010 0.97
22 Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time. BJU Int 2008 0.96
23 The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011). Trials 2012 0.95
24 Advances in bladder cancer imaging. BMC Med 2013 0.93
25 Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J 2010 0.92
26 Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial. J Cancer 2011 0.88
27 Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation. Int J Radiat Oncol Biol Phys 2010 0.88
28 Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors. Neoplasia 2005 0.86
29 Prospective study of factors predicting adherence to medical advice in men with testicular cancer. J Clin Oncol 2009 0.86
30 A randomised trial of accelerated radiotherapy for localised invasive bladder cancer. Radiother Oncol 2004 0.84
31 Surveillance in stage I seminoma patients: a long-term assessment. Eur Urol 2009 0.83
32 Testicular germ cell tumours. BMJ 2013 0.82
33 Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clones. Oncogene 2004 0.81
34 Younger age-at-diagnosis for familial malignant testicular germ cell tumor. Fam Cancer 2009 0.80
35 Minimizing toxicity in early-stage testicular cancer treatment. Expert Rev Anticancer Ther 2012 0.78
36 Can digitally reconstructed radiographs (DRRS) replace simulation films in prostate cancer conformal radiotherapy? Int J Radiat Oncol Biol Phys 2003 0.77
37 Selective organ preservation for the treatment of muscle-invasive transitional cell carcinoma of the bladder: a review of current and future perspectives. Expert Rev Anticancer Ther 2014 0.77
38 Prostate-specific antigen velocity in untreated, localized prostate cancer. BJU Int 2007 0.77
39 Testicular cancer: changing patterns of incidence in testicular germ cell tumours. Nat Rev Urol 2013 0.76
40 Retroperitoneal lymph-node dissection after chemotherapy for germ cell cancer in patients with elevated tumor markers. Nat Clin Pract Urol 2006 0.76
41 Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility. Nat Commun 2016 0.75
42 Polygenic susceptibility to testicular cancer: implications for personalised health care. Br J Cancer 2016 0.75
43 The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivation. Int J Radiat Oncol Biol Phys 2004 0.75